MedTrace Logo

Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study

NCT06954792 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-02-12

No results posted yet for this study

Summary

TTVR-AHI is a multicenter, retrospective registry including heart failure patients displaying a severe and symptomatic tricuspid regurgitation (TR), deemed non-eligible to cardiac surgery and therefore treated with transcatheter tricuspid valve replacement (TTVR) devices. This substudy of the main registry will focus on those with post-procedural acute hemodynamic instability (AHI).

Conditions

  • Tricuspid Regurgitation
  • Heart Failure
  • Structural Heart Disease
  • Interventional Cardiology

Sponsors & Collaborators

Principal Investigators

  • Tamim Nazif, MD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-31
Primary Completion
2029-05-01
Completion
2029-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06954792 on ClinicalTrials.gov